Aigen Investment Management’s Norwegian Cruise Line NCLH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Buy
61,557
+40,888
+198% +$893K 0.3% 96
2025
Q4
$461K Sell
20,669
-17,632
-46% -$372K 0.11% 255
2025
Q3
$943K Buy
+38,301
New +$930K 0.15% 211
2024
Q2
Sell
-73,806
Closed -$1.54M 937
2024
Q1
$1.54M Buy
+73,806
New +$1.34M 0.34% 76
2023
Q4
Sell
-62,605
Closed -$1.03M 976
2023
Q3
$1.03M Buy
+62,605
New +$1.15M 0.19% 155
2023
Q1
Sell
-25,739
Closed -$315K 750
2022
Q4
$315K Sell
25,739
-61,060
-70% -$919K 0.04% 355
2022
Q3
$986K Buy
+86,799
New +$1.14M 0.14% 191
2022
Q1
Sell
-346,908
Closed -$7.1M 893
2021
Q4
$7.1M Buy
+346,908
New +$8.3M 0.44% 40
2021
Q1
Sell
-19,246
Closed -$489K 800
2020
Q4
$489K Buy
+19,246
New +$402K 0.06% 395

Other funds holding NCLH

Aigen Investment Management's NCLH Position: Q1 2026 in Review

Aigen Investment Management increased its Norwegian Cruise Line (NCLH) stake by 198% in Q1 2026, buying an estimated $893K and bringing the position to 61,557 shares worth $1.15M. The position accounts for 0.3% of the portfolio, ranked #96.

Aigen Investment Management first reported a position in NCLH in Q4 2020 and has held it in 9 quarters since. The position peaked at $7.1M in Q4 2021. 634 funds tracked by Wall St. Rank hold NCLH as of Q1 2026.

  • Aigen Investment Management held 61,557 shares of Norwegian Cruise Line worth $1.15M as of Q1 2026.
  • Aigen Investment Management bought 40,888 Norwegian Cruise Line shares in Q1 2026, an estimated $893K.
  • Norwegian Cruise Line made up 0.3% of Aigen Investment Management's portfolio in Q1 2026, its #96 holding.
  • Aigen Investment Management first reported a position in Norwegian Cruise Line in Q4 2020 and has held it in 9 quarters since.
  • Aigen Investment Management's Norwegian Cruise Line position peaked at $7.1M in Q4 2021.
  • 634 funds tracked by Wall St. Rank held Norwegian Cruise Line as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.